| [1］ Zhao N， Zhang AS， Enns CA. Iron regulation by hepcidin［J］. J Clin Invest， 2013，123（6）：2337-2343. [2］ Origa R， Galanello R， Ganz T， et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia［J］. Haematologica， 2007，92（5）：583-588. [3］ Pennell DJ，Udelson JE，Arai AE，et al. Cardiovascular function and treatment in β-thalassemia major： a consensus statement from the American Heart Association［J］. Circulation，2013，128（3）：281-308. [4］ Musallam KM，Rivella S，Vichinsky E，et al. Non-transfusion- dependent thalassemias［J］. Haematologica，2013，98（6）：833-844. [5］ Ge XH，Wang Q，Qian ZM，et al. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes［J］. J Nutr Biochem， 2009，20（11）：860-865. [6］ Taher AT，Viprakasit V，Musallam KM，et al. Treating iron overload in patients with non-transfusion-dependent thalassemia［J］. Am J Hematol， 2013，88（5）：409-415. [7］ Carpenter JP， He T， Kirk P， et al. On T2* magnetic resonance and cardiac iron［J］. Circulation，2011，123（14）：1519-1528. [8］ Anderson LJ， Holden S， Davis B， et al. Cardiovascular T2-star （T2*） magnetic resonance for the early diagnosis of myocardial iron overload［J］. Eur Heart J，2001，22（23）：2171-2179. [9］ Eghbali A， Taherahmadi H， Shahbazi M， et al. Association between serum ferritin level， cardiac and hepatic T2-star MRI in patients with major β-thalassemia［J］. Iran J Ped Hematol Oncol，2014，4（1）：17-21. [10］ Modell B， Khan M， Darlison M， et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance［J］. J Cardiovasc Magn Reson，2008，10：42-50. [11］ Au WY，Lam WW，Chu WW，et al. A cross-sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong［J］. Haematologica，2008，93（5）：784-786. [12］ Noetzli LJ，Mittelman SD，Watanabe RM，et al. Pancreatic iron and glucose dysregulation in thalassemia major［J］. Am J Hematol， 2012，87（2）：155-160. [13］ Evans P，Kayyali R，Hider RC，et al. Mechanisms for the shuttling of plasma non-transferrin-bound iron （NTBI） onto deferoxamine by deferiprone［J］. Transl Res， 2010，156（2）：55-67. [14］ Lucas GN， Perera BJ， Fonseka EA， et al. Experience with the oral iron chelator deferiprone in transfusion-dependent children［J］. Ceylon Med J，2002，47（4）：119-121. |
